CTOR — Citius Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- $52.16m
- $55.96m
Annual cashflow statement for Citius Oncology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.01 | 0.381 | 2.42 | -21.1 |
| Deferred Taxes | ||||
| Non-Cash Items | — | -0.493 | -3.43 | 7.5 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.01 | 0.064 | 0.412 | 13.2 |
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 0 | -0.048 | -0.601 | 0.126 |
| Other Investing Cash Flow Items | — | -67.3 | -1.32 | -5 |
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | -67.3 | -1.32 | -5 |
| Financing Cash Flow Items | — | 1.76 | 0.345 | 1.07 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | — | 67.7 | 1.66 | 4.87 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 0.289 | -0.256 | 0 |